Tris(4-(1H-imidazol-1-yl)phenyl)amine

Catalog No. :
ACSUGB187
CAS No. :
1258947-79-3
Molecular Formula :
C27H21N7
Molecular Weight :
443.51

IUPAC Name:tris(4-(1H-imidazol-1-yl)phenyl)amine

Tris(4-(1H-imidazol-1-yl)phenyl)amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$79.00Login to see priceIn stockInquiry
5g97%$337.00Login to see priceIn stockInquiry
25g97%$1387.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameTris(4-(1H-imidazol-1-yl)phenyl)amine
IUPAC Nametris(4-(1H-imidazol-1-yl)phenyl)amine
MDL No.MFCD28559405
Molecular FormulaC27H21N7
Molecular Weight443.51
SMILESN(C1=CC=C(N2C=CN=C2)C=C1)(C3=CC=C(N4C=CN=C4)C=C3)C5=CC=C(N6C=CN=C6)C=C5
InChI KeyXXDCQSZBEIDWSY-UHFFFAOYSA-N
SynonymTris[4-(1H-imidazol-1-yl)-phenyl]amine;4-(1H-imidazol-1-yl)-N,N-bis[4-(1H-imidazol-1-yl)phenyl]aniline;Benzenamine, 4-(1H-imidazol-1-yl)-N,N-bis[4-(1H-imidazol-1-yl)phenyl]-;Tris[4-(1-imidazolyl)phenyl]amine;DK7696;4-imidazol-1-yl-N,N-bis(4-imidazol-1-ylphenyl)aniline
CAS No.1258947-79-3
PubChem CID60197033

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSUGB187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACSUGB187 route product structure diagram
    ACSUGB1871258947-79-3 In Stock
Inquiry

2. ACSUGB187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSUGB187 route product structure diagram
    ACSUGB1871258947-79-3 In Stock
Inquiry

Comments (0)